Lamotrigine Restart Considerations with Concomitant Antiepileptic Drugs

Metabolic Interactions

Valproic acid markedly inhibits lamotrigine metabolism, leading to higher plasma concentrations and necessitating dose reductions when restarting lamotrigine 1
During re‑titration of lamotrigine in patients receiving valproic acid, the target daily dose should be approximately 50 % of the dose used in patients not on valproic acid 1
Enzyme‑inducing antiepileptic drugs such as phenytoin, carbamazepine, and phenobarbital increase lamotrigine clearance, allowing for higher or more rapid dose escalation if re‑initiation is required 1

In the first two weeks after lamotrigine restart, the incidence of rash ranges from 10 % to 17 % with lamotrigine versus 6 % to 10 % with placebo, underscoring the need for close monitoring 1

Precise dosing of lamotrigine is essential because the drug must be carefully titrated to reduce the risk of severe skin reactions such as Stevens‑Johnson syndrome. 2

Tablet splitting should only be performed when it is part of a dose adjustment prescribed by the treating clinician, ensuring that the intended therapeutic regimen is maintained. 2